WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

20.45 -0.1

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.32

Max

20.51

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	21.567 28.852
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+90.9% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-27M 355M
Ankstesnė atidarymo kaina	20.55
Ankstesnė uždarymo kaina	20.45

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-14 22:53; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

2025-12-13 00:04; UTC

Įsigijimai, susijungimai, perėmimai

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

2025-12-14 23:46; UTC

Rinkos pokalbiai

Gold Edges Higher Amid Some Tailwinds -- Market Talk

2025-12-14 23:36; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025-12-14 22:38; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue to Take Full Control of US$101M Copper Miner Alta

2025-12-14 22:02; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

2025-12-14 22:01; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue: Alta Owns the Canariaco Project in Northern Peru

2025-12-14 22:01; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

2025-12-14 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue: Agreement Implies Total Equity Value of C$139 Million

2025-12-14 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

2025-12-14 21:59; UTC

Įsigijimai, susijungimai, perėmimai

Fortescue to Acquire Remaining 64% of Alta Copper

2025-12-14 17:00; UTC

Uždarbis

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

2025-12-14 08:30; UTC

Įsigijimai, susijungimai, perėmimai

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

2025-12-13 16:48; UTC

Įsigijimai, susijungimai, perėmimai

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

2025-12-13 08:00; UTC

Įsigijimai, susijungimai, perėmimai

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

2025-12-13 07:00; UTC

Įsigijimai, susijungimai, perėmimai

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

2025-12-13 00:24; UTC

Įsigijimai, susijungimai, perėmimai

Want a Piece Of SpaceX? -- Barrons.com

2025-12-12 23:49; UTC

Įsigijimai, susijungimai, perėmimai

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

2025-12-12 22:52; UTC

Rinkos pokalbiai

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

2025-12-12 22:32; UTC

Uždarbis

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

2025-12-12 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-12 20:45; UTC

Uždarbis

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

2025-12-12 20:41; UTC

Rinkos pokalbiai

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

2025-12-12 20:20; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

2025-12-12 19:23; UTC

Uždarbis

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

2025-12-12 18:35; UTC

Įsigijimai, susijungimai, perėmimai

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

2025-12-12 18:33; UTC

Įsigijimai, susijungimai, perėmimai

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

2025-12-12 18:31; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

2025-12-12 17:49; UTC

Uždarbis

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

2025-12-12 17:34; UTC

Įsigijimai, susijungimai, perėmimai

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

90.9% į viršų

12 mėnesių prognozė

Vidutinis 39 USD 90.9%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.